Stock Events

Stock Events

Guided Therapeutics 

$0.150000
8
+$0.01+3.67%Friday 17:29

Statistics

Day High
0.1501
Day Low
0.15
52W High
0.54
52W Low
0.132
Volume
5,740
Avg. Volume
26,842
Mkt Cap
14.48M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Nov 11Expected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.09
-0.06
-0.03
0
Expected EPS
0
Actual EPS
-0.03

Financials

-436.25%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
767,000Revenue
-3.35MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Danaher
DHR
Mkt Cap150.48B
Danaher Corporation operates in the diagnostics segment, offering products that compete with GTHP's cancer detection technologies.
Baxter International
BAX
Mkt Cap12.14B
Baxter International Inc. provides a range of hospital and renal products, including diagnostic tools that could compete with GTHP's offerings.
Boston Scientific
BSX
Mkt Cap61.74B
Boston Scientific Corporation develops, manufactures, and markets medical devices that are used in various interventional medical specialties, potentially competing with GTHP's diagnostic solutions.
Medtronic
MDT
Mkt Cap110.49B
Medtronic plc offers medical technologies, services, and solutions, including diagnostic products that could compete with GTHP's technology.
GE Aerospace
GE
Mkt Cap321.19B
General Electric Company, through its healthcare segment, provides medical imaging, monitoring, biomanufacturing, and cell therapy technology, competing in the broader diagnostics market.
Koninklijke Philips N.V.
PHG
Mkt Cap23.38B
Koninklijke Philips N.V. offers diagnostic imaging, patient monitoring, and health informatics as well as consumer health and home care, competing in the medical diagnostics field.
Resmed
RMD
Mkt Cap30.78B
ResMed Inc. specializes in cloud-connectable medical devices for sleep apnea, COPD, and other chronic diseases, indirectly competing with GTHP's diagnostic technologies.
Stryker
SYK
Mkt Cap105.65B
Stryker Corporation specializes in medical and surgical equipment and neurotechnology and spine products, potentially competing with GTHP's diagnostic technologies in certain applications.

About

Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.
Show More
CEO
Mark L. Faupel
Employees
3
Country
United States
ISIN
US40171F5017

Listings

OTC Link
US
GTHP

0 Comments

Share your thoughts

FAQs

What is Guided Therapeutics stock price today?▼
The current price of GTHP is $0.15 USD — it has increased by +3.67% in the past 24 hours. Watch Guided Therapeutics stock price performance more closely on the chart.
What is Guided Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Guided Therapeutics stocks are traded under the ticker GTHP.
Is Guided Therapeutics stock price growing?▼
GTHP stock has risen by +3.45% compared to the previous week, the month change is a -39.52% fall, over the last year Guided Therapeutics has showed a -32.14% decrease.
What is Guided Therapeutics market cap?▼
Today Guided Therapeutics has the market capitalization of 14.48M
What were Guided Therapeutics earnings last quarter?▼
GTHP earnings for the last quarter are -0.03 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Guided Therapeutics revenue for the last year?▼
Guided Therapeutics revenue for the last year amounts to 767,000 USD.
What is Guided Therapeutics net income for the last year?▼
GTHP net income for the last year is -3.35M USD.
How many employees does Guided Therapeutics have?▼
As of November 1, 2026, the company has 3 employees.
In which sector is Guided Therapeutics located?▼
Guided Therapeutics operates in the Health & Wellness sector.
When did Guided Therapeutics complete a stock split?▼
The last stock split for Guided Therapeutics was on March 29, 2019 with a ratio of 1:800.
Where is Guided Therapeutics headquartered?▼
Guided Therapeutics is headquartered in Peachtree Corners, United States.